MARKET

PAVMW

Pavmed
PAVMW
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-2.4153
-
0.0702
-
PAVmed names Joseph Virgilio SVP, chief business officer for medical devices
Reuters · 1d ago
PAVmed FY25 net loss narrows to $3.8 million; revenue falls to $0.1 million
Reuters · 4d ago
PAVMED INC - Q4 2025 NON-GAAP ADJ LOSS $0.9 MLN, $1.05 PER SHARE
Reuters · 4d ago
PAVmed held a special shareholder meeting; 54.1% of voting power was represented by proxy or in person
Reuters · 03/27 21:16
PAVmed FY2025 revenue drops 96.67% to $0.1 million; operating cash outflow narrows 40% to $5.2 million
Reuters · 03/27 21:09
Lucid Diagnostics FY2025 net loss widens to $58 million; revenue rises 8.28% to $4.7 million
Reuters · 03/26 12:02
Lucid Diagnostics FY2025 operating loss widens to $58 million; revenue rises 9.3% to $4.7 million
Reuters · 03/25 20:57
PAVmed Inc. to Host Business Update Conference Call and Webcast
Reuters · 03/16 13:03
More

Webull offers Pavmed stock information, including NASDAQ: PAVMW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PAVMW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PAVMW stock methods without spending real money on the virtual paper trading platform.